CIK 0001833141 · <br>Emerging growth company
Helus Pharma Inc.
Sign in to watch- Ticker
- HELP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- British Columbia, Canada
- Entity type
- other
- Phone
- (908) 764-8385
- Business address
- 100 KING STREET WEST, SUITE 5600, TORONTO, Ontario, Canada
- Former names
- CYBIN INC.
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at $13.47 ($1,347,050)
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Growth Officer bought 100,000 shares at $12.47 ($1,247,190)
- 4 Open-market buy Chief Growth Officer bought 100,000 shares at $12.47 ($1,247,190)
- 4 Open-market buy Executive Chair bought 100,000 shares at $12.39 ($1,238,670)
- 6-K Event Report of Foreign Issuer
- 4 Open-market buy Executive Chair bought 100,000 shares at $12.09 ($1,208,900)
- 4 Open-market buy Chief Growth Officer bought 100,000 shares at $11.78 ($1,178,280)
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Executive Chair bought 95,000 shares at $11.81 ($1,121,475)
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Chief Growth Officer bought 90,000 shares at $11.59 ($1,042,677)
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 2 of 23 · 454 filings